4//SEC Filing
Barth Jay 4
Accession 0001209191-20-044005
CIK 0001178879other
Filed
Jul 28, 8:00 PM ET
Accepted
Jul 29, 9:41 PM ET
Size
9.9 KB
Accession
0001209191-20-044005
Insider Transaction Report
Form 4
Barth Jay
Chief Medical Officer
Transactions
- Sale
Common Stock
2020-07-27$15.05/sh−30,000$451,377→ 163,204 total - Exercise/Conversion
Stock Options (right to buy)
2020-07-27−30,000→ 30,000 totalExercise: $6.10Exp: 2026-06-15→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2020-07-27$6.10/sh+30,000$183,000→ 193,204 total
Holdings
- 20(indirect: By Daughter)
Common Stock
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]This price is the weighted average price for the transactions reported on this line. The prices for the transactions reported on this line range from $14.65 to $15.27 inclusive. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]All of the options were fully vested and exercisable as of the transaction date.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001601896
Filing Metadata
- Form type
- 4
- Filed
- Jul 28, 8:00 PM ET
- Accepted
- Jul 29, 9:41 PM ET
- Size
- 9.9 KB